Background <p>Postoperative pulmonary complications (PPCs) are severe and are of particular concern in older adult patients undergoing laparoscopic gastrointestinal surgery. Both 40% and 80% fraction of inspired oxygen (FiO<sub>2</sub>) are commonly used for anesthesia. Presently, whether 40% FiO<sub>2</sub> can increase the oxygenation index of patients 48&#xa0;h postoperatively and reduce PPCs remains controversial. Moreover, no clear consensus exists for older adult patients. Therefore, this study aims to compare the effects of low FiO<sub>2</sub> (40%) and high FiO<sub>2</sub> (80%) levels on postoperative pulmonary function in older adult study participants undergoing laparoscopic gastrointestinal surgery.</p> Methods <p>This multicenter, prospective, parallel-cohort, randomized controlled clinical trial will include 1098 older adult participants aged ≥ 65 years old undergoing laparoscopic gastrointestinal surgery, from 16 clinical trial sites across China. Participants will be randomized, as per a 1:1 ratio to two cohorts, the “L” and “H” cohorts, to receive low FiO<sub>2</sub> (40%) and high FiO<sub>2</sub> (80%) levels, respectively. The primary outcome measure is the 48-h postoperative oxygenation index between the two cohorts. The secondary outcome measures include the other blood gas analysis results, PPCs within 7&#xa0;days, and 30-day mortality rate.</p> Discussion <p>This study of elderly patients undergoing laparoscopic gastrointestinal surgery with different intraoperative oxygen concentrations at high risk for pulmonary complications. All subjects were followed up for up to 30&#xa0;days for pulmonary function, postoperative complications, etc. Randomization was performed separately at 16 sites.</p> Trial registration <p>ClinicalTrials.gov NCT06359106. Registered and posted on April 11, 2024.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Effects of varying inhaled oxygen concentrations on lung function in older adult patients undergoing laparoscopic gastrointestinal surgery under general anesthesia: protocol of a prospective multicenter clinical study in China

  • Tianhao Zhang,
  • Yang An,
  • Shiling Zhao,
  • Fei Han,
  • Lining Huang,
  • Li Wang,
  • Jianbo Wu,
  • Qian Lei,
  • Kun Wang,
  • Jianlin Shao,
  • Yun Wang,
  • Yong Luan,
  • Wei Feng,
  • Jiannan Song,
  • Zeqing Huang,
  • Chaoran Wu,
  • Yongshan Nan,
  • Bing Tang,
  • Xijia Sun,
  • Wenfei Tan

摘要

Background

Postoperative pulmonary complications (PPCs) are severe and are of particular concern in older adult patients undergoing laparoscopic gastrointestinal surgery. Both 40% and 80% fraction of inspired oxygen (FiO2) are commonly used for anesthesia. Presently, whether 40% FiO2 can increase the oxygenation index of patients 48 h postoperatively and reduce PPCs remains controversial. Moreover, no clear consensus exists for older adult patients. Therefore, this study aims to compare the effects of low FiO2 (40%) and high FiO2 (80%) levels on postoperative pulmonary function in older adult study participants undergoing laparoscopic gastrointestinal surgery.

Methods

This multicenter, prospective, parallel-cohort, randomized controlled clinical trial will include 1098 older adult participants aged ≥ 65 years old undergoing laparoscopic gastrointestinal surgery, from 16 clinical trial sites across China. Participants will be randomized, as per a 1:1 ratio to two cohorts, the “L” and “H” cohorts, to receive low FiO2 (40%) and high FiO2 (80%) levels, respectively. The primary outcome measure is the 48-h postoperative oxygenation index between the two cohorts. The secondary outcome measures include the other blood gas analysis results, PPCs within 7 days, and 30-day mortality rate.

Discussion

This study of elderly patients undergoing laparoscopic gastrointestinal surgery with different intraoperative oxygen concentrations at high risk for pulmonary complications. All subjects were followed up for up to 30 days for pulmonary function, postoperative complications, etc. Randomization was performed separately at 16 sites.

Trial registration

ClinicalTrials.gov NCT06359106. Registered and posted on April 11, 2024.